Ethanol extract of Cassia sieberiana leaves ameliorates deviances associated with benign prostatic hyperplasia in rats

References

• Aakula A, Kohonen P, Leivonen S. 2016. Systematic identification of microRNAs that impact on proliferation of prostate cancer cells and display changed expression in tumor tissue. Eur Urol 69(6):1120–1128.
   PubMed Web of Science ®Google Scholar
• Abell LL, Levey BB, Brodie BB, Kendall FE. 1952. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 195(1):357–366.
   PubMed Web of Science ®Google Scholar
• Aebi HE. 1983. Catalase. In: Bergmeyer H. U., J. Bergmeyer, Grassl M., editor. Methods of Enzymatic Analysis. 3rd ed. Florida: Weinheim Deerfield Beach; p. 273–285.
   Google Scholar
• Afriyie DK, Asare GA, Bugyei K, Adjei S, Lin JM, Peng J, Hong ZF. 2014. Treatment of benign prostatic hyperplasia with croton membranaceus in an experimental animal model. J Ethnopharmacol. 157:90–98.
   Web of Science ®Google Scholar
• Agbo MO, Okoye FBC, Nwodo JN. 2010. In vivo antiinflammatory effect of Zapoteca portoricensis. Int J Health Res. 3(1):29–35.
   Google Scholar
• Al-Trad B, Aljabali A, Al Zoubi M, Shehab M, Omari S. 2019. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats. Int J Nanomed. 14:3145–3154.
   PubMed Web of Science ®Google Scholar
• Albers JJ, Warmick GR, Cheng MC. 1978. Quantitation of high density lipoproteins. Lipids. 13:926–932.
   PubMed Web of Science ®Google Scholar
• Aliyu Z, Yusha’u M, Aliyu BS. 2013. Anti malarial activity of Cassia sieberiana leaf extracts. Open Conf Proc J. 4:72–76.
   Google Scholar
• Aryal M, Pandeya A, Gautam N, Baral N, Lamsal M. 2007. Oxidative stress in benign prostatic hyperplasia. Nepal Med Coll J. 9(4):222–224.
   PubMedGoogle Scholar
• Awomukwu DA, Nyananyo BL, Ikpeama AI, Adieze CU. 2015. Comparative chemical constituents of some Cassia species and their pharmacognistic importance in south eastern Nigeria. Sci. J. Chem. 3(3):40–49.
   Google Scholar
• Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten O, Özgök Y, Dimovski A. 2006. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem. 39:176–179.
   PubMed Web of Science ®Google Scholar
• Babson AL, Greeley SJ, Coleman CM, Philips GE. 1966. Phenolphthalein monophosphate as a substrate for serum alkaline phosphatase. Clin Chem. 12(8):482–490.
   PubMed Web of Science ®Google Scholar
• Bhavsar A, Verma S. 2014. Anatomic imaging of the prostate. Biomed Res Int. 1–9.
   Google Scholar
• Boumerfeg S, Baghiani A, Messaoudi D, Khennouf S, Arrar L. 2009. Antioxidant properties and xanthine oxidase inhibitory effects of Tamus communis L. root extracts. Phytother Res. 23:283–288.
   PubMed Web of Science ®Google Scholar
• Braeckman J, Denis L. 2017. Management of BPH then 2000 and now 2016 – from BPH to BPO. Asian J Urol. 4:138–147.
   PubMed Web of Science ®Google Scholar
• Bullock TL, Andriole GL. 2006. Emerging drug therapies for benign prostatic hyperplasia. Expert Opin Emerg Drugs. 11:111–123.
   PubMedGoogle Scholar
• Cartwright R, Mangera A, Tikkinen KAO, Rajan P, Pesonen J, Kirby AC, Thiagamoorthy G, Ambrose C, Gonzalez-Maffe J, Bennett PR, et al. 2014. Systematic review and meta-analysis of candidate gene association studies of lower uri-nary tract symptoms in men. Eur Urol. 66(4):752–768.
   Web of Science ®Google Scholar
• Donkor K, Okine KNL, Abotsi, MKW, Woode E. 2013. Anti-inflammatory and anti-nociceptive effects of ethyl acetate fraction of root bark of Cassia sieberiana D. C. in Murine models. C. in Murine models. Pharmacologia. 4(4):301-310.
   Google Scholar
• Drury RA, Wallington A, Cameroun SR. 1967. Carleton’s histological techniques. New York: Oxford University Press; p. 1–420.
   Google Scholar
• Duru RC, Njoku OU, Maduka IC, Ugonabo MC, Ugwueme FO. 2015. Atherogenic lipid markers and testosterone levels in Nigerian men with prostate disorders. Asian Pacific J Health Sci. 2:48–55.
   Google Scholar
• Duwiejua M, Panyin AB, Weremfo A, Woode E, Ansah C. 2007. Antinociceptive activity of the ethanolic extract of the root bark of Cassia sieberiana (Fam. Caesalpinaceae). J Pharm Biores. 4(2):49–58.
   Google Scholar
• Ejike CECC, Ezeanyika LUS. 2011. Management of experimental benign prostatic hyperplasia in rats using a feedbased therapy containing Telfairia occidentalis seeds. Afr J Tradit Complement Altern Med. 8(4):398–404.
   Google Scholar
• Fridovich I. 1989. Superoxide dismutase: An adaptation to a pragmatic gas. J Biol Chem. 264:7761–7764.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredricson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. J Clin Chem. 18:499–502.
   Google Scholar
• Goldberg DM,Spooner RJ. 1983. Assay of Glutathione Reductase. In: Bergmeyen H. V., editor. Methods of Enzymatic Analysis, 3rd ed. Vol. 3, Deerfiled Beach: Verlog Chemie; p. 258–265.
   Google Scholar
• Hagberg KW, Divan HA, Persson R, Nickel JC, Jick SS. 2016. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the clinical practice research datalink. Br Med J. 354:1–15.
   Google Scholar
• Ikeyi AP, Okagu IU, Ezeanyika LUS, Alumanah EO. 2020. Zapotecaportoricensis root crude methanol extract and its fractions normalizes aberrations associated with benign prostatic hyperplasia in rats. All Life. 13(1):360–372.
   Web of Science ®Google Scholar
• Indian Council of Medical Research. 2001. Guidelines for the use of laboratory animals in medical colleges. New Delhi: Academic Press; p. 3–13.
   Google Scholar
• Joshua PE, Ezugwu CH, Chilaka FC, Nwodo OFC, Dasofunjo K, Ezugwu MU. 2018. Effect of ethanol extract of Zapoteca portoricensis stem on testosterone-induced benign prostate hyperplasia (BPH) in adult male albino rats. Australian J Basic Appl Sci. 12(12):9–18.
   Google Scholar
• Li J, Tian Y, Guo S, Gu H, Yuan Q, Xie X. 2018. Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms. PLoS ONE. 13(1):1–13.
   Web of Science ®Google Scholar
• Liao CH, Li HY, Chung SD, Chiang HS, Yu HJ. 2012. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40–79 years. Aging Male. 15(1):28–33.
   PubMed Web of Science ®Google Scholar
• Liu J, Fang T, Li M, Song Y, Li J, Xue Z, Li J, Bu D, Liu W, Zeng Q, et al. 2019. Pao pereira extract attenuates testosteroneinduced benign prostatic hyperplasia in rats by inhibiting 5α-reductase. Sci Rep. 9:19703–19711.
   Web of Science ®Google Scholar
• Liu Y, Zuckier LS, Ghesani NV. 2010. Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach. Anticancer Res. 30:369–374.
   Web of Science ®Google Scholar
• Mbaka G, Anunobi C, Ogunsina S, Osiagwu D. 2017. Histomorphological changes in induced benign prostatic hyperplasia with exogenous testosterone and estradiol in adult male rats treated with aqueous ethanol extract of Secamone afzelii. Egypt J Basic Appl Sci. 4:15–21.
   Google Scholar
• Mimae R. 2017. Liver enzymes as an indicator of hepatic insult. J Healthcare Hyg. 1(1):1–4.
   Google Scholar
• Mohamed DA, Rashed MM, Shallan M, Fouda K, Hanna LM. 2016. Amelioration of benign prostate hyperplasia in rats through plant foods. Int J Pharmacogn Phytochem Res. 8(12):2063–2070.
   Google Scholar
• Moke EG, Ilodigwe EE, Okonta JM, Emudainohwo Jot, Ajaghaku DL, Erhirhie OE, Chinwuba P, Ahante E. 2015. Antidiabetic activity and toxicity evaluation of aqueous extracts of Spondias mombin and Costus afer on wistar rats. British J Pharm Res. 6(5):333–342.
   Google Scholar
• Mustafa M, Salih AF, Illzam EM, Sharifa AM, Suleiman M, Hussain SS. 2016. Prostate cancer: pathophysiology, diagnosis, and prognosis. IOSR J Dent Med Sci. 15(6):4–11.
   Google Scholar
• Olapade AA, Akinoso R, Oduwaye AO. 2012. Changes in some physicochemical properties of Cassia sieberiana seeds during roasting. Niger. Food J. 30(1):26–34.
   Google Scholar
• Park KH, Kim KS, Lee WS, Chung J, Lee B, Na WS, Park GC, Kim OY. 2017. A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosteroneinduced benign prostatic hyperplasia in male Wistar rats. Saudi J Biol Sci. 24:1555–1561.
   PubMed Web of Science ®Google Scholar
• Parsons JK, Bergstrom J, Barrett-Connor E. 2008. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int. 101:313–318.
   PubMed Web of Science ®Google Scholar
• Rafieian-Kopaei M. 2012. Medicinal plants and the human needs. J Herbmed Pharmacol. 1(1):1–2.
   Google Scholar
• Reitman S, Frankel S. 1957. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 28:56–63.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG, Nuckolls JG, Wei JT, Steers W. 2007. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics. BJU Int. 100:813–819.
   PubMed Web of Science ®Google Scholar
• Sakagami H., Jiang Y., Kusama K., Atsumi T., Ueha T., Toguchi M., Iwakura I., Satoh K., Ito H., Hatano T., Yoshida T. 2000. Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines — a possible mechanism. Phytomedicine. 7:39–47.
   PubMed Web of Science ®Google Scholar
• Sam GH, Mensah MLK, Nyakoa-Ofori N. 2011. Pharmacognostic studies and standardization of Cassia sieberiana roots. Pharmacogn J. 3(21):12–17.
   Google Scholar
• Singh D. 2017. Leaf phenology of Cassia sieberiana L. in Ksusta campus of Kebbi State, Nigeria. Sci Technol Public Policy. l(1):23–28.
   Google Scholar
• Singh R. 2015. Medicinal plants: A review. J Plant Sci. 3(1):50–55.
   Google Scholar
• Sliva O, Ferreira E, Vaz-pato M, Gome E. 1997. Guinea Bissau’s plant vitro susceptibility studies on Neisseria gonorrhoeae. Int J Pharm. 35(5):323–328.
   Google Scholar
• Sy GY, Fall AD, Diatta W, Gueye M, Badji K, Bassène E, Faye B. 2009. Analgesic and anti-inflammatory activity of aqueous root extract of Cassia sieberiana DC (Caesalpiniaceae). Afr J Pharm Pharmacol. 3(12):651–653.
   Google Scholar
• Tewari R, Prabhat P, Natu SM, Dalela D, Goel A, Goel MM, Tandon P. 2011. Association of benign prostatic hyperplasia (BPH) with the metabolic syndrome (MS) and its components – ‘a growing dilemma’. J Men’s Health. 8(2):66–71.
   Google Scholar
• Thu HE, Mohamed IN, Hussain Z, Jayusman PA, Shuid AN. 2017. Eurycoma longifolia as a potential adoptogen of male sexual health: a systematic review on clinical studies. Chin J Nat Med. 15(1):71–80.
   Web of Science ®Google Scholar
• Tietz NW. 1990. Clinical Guide to Laboratory tests (ELISA). 2nd ed. Philadelphia: W. B. Saunders, Company. pp. 932–933.
   Google Scholar
• Traish AM, Morgentaler A. 2013. RE: Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. J Steroid Biochem Mol Biol. 138:462–463.
   Google Scholar
• Trost L, Saitz TR, Hellstrom WJG. 2013. Side effects of 5-alpha reductase inhibitors: a comprehensive review. Sex Med Rev. 1(1):24–41.
   PubMedGoogle Scholar
• Veeresh Babu SV, Veeresh B, Patill AA, Warke YB. 2010. Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats. Eur J Pharmacol. 626:262–265.
   Web of Science ®Google Scholar
• Velonas VM, Woo HH, Remedios CG, Assinder SJ. 2013. Current status of biomarkers for prostate cancer. Int J Mol Sci. 14:11034–11060.
   PubMed Web of Science ®Google Scholar
• Wallin B, Rosengren B, Shertzer HG, Camejo G. 1993. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem. 208:10–15.
   PubMed Web of Science ®Google Scholar
• Yano M, Yasuda K, Kitahara S, Nakajima C, Iimura Y, Yamanishi T. 2001. The reason why prostatic hyperplasia causes lower urinary track symptoms. Asian Med J. 44(2):91–96.
   Google Scholar